A substance or therapy that reduces anxiety.

A CBD extract that contains multiple cannabinoids and terpenes, but no detectable THC.

A non-intoxicating cannabinoid found in cannabis. Used therapeutically for anxiety, pain, inflammation, and more.

A type of compound found in the cannabis plant, including CBD and THC. Some are psychoactive (e.g., THC), while others are not (e.g., CBD).

Pure cannabidiol with 0.0% THC. Used in Kazmira’s prescription formulations.

A strong desire to use a substance (e.g., alcohol or opioids). Often addressed in addiction support protocols.

A system of receptors in the body that helps regulate sleep, pain, mood, inflammation, and immune function.

A CBD extract containing all cannabinoids, including trace amounts of THC. Not used in Kazmira products.

Does not affect perception, cognition, or cause a “high.”

A category of therapies designed to help reduce cravings, support emotional regulation, and improve recovery outcomes in patients with substance use disorders.

Persistent pain that lasts for 12 weeks or more. Common conditions include arthritis, fibromyalgia, and lower back pain.

A group of symptoms involving memory loss, cognitive decline, and impaired reasoning. Some patients use CBD to support sleep and mood.

A mood disorder characterized by persistent sadness, fatigue, and loss of interest. CBD may support emotional regulation and resilience.

A chronic pain disorder involving widespread musculoskeletal pain, fatigue, and cognitive issues. CBD may offer adjunct support.

Emotional and psychological well-being. CBD may support aspects of mental health under provider guidance.

The process of regulating emotional highs and lows. A key goal in therapies for anxiety, PTSD, and addiction.

A term encompassing brain health, cognitive function, and emotional stability. Common use cases include PTSD, dementia, and anxiety.

Nerve pain or dysfunction, often supported with anti-inflammatory or neuroprotective compounds like CBD.

A chronic condition characterized by opioid misuse and dependence. CBD may aid in withdrawal support and anxiety relief.

A medical approach to managing chronic or acute pain. Kazmira’s CBD formulations are often used in this context.

A mental health condition triggered by trauma. CBD may support sleep, anxiety, and emotional regulation.

A common symptom in PTSD, anxiety, and dementia. CBD may support improved sleep cycles.

A subtype of anxiety triggered by past events. CBD may reduce symptom severity and improve emotional resilience.

A type of compounding pharmacy governed by Section 503A of the Federal Food, Drug, and Cosmetic Act. 503A pharmacies compound custom medications based on individual prescriptions and are not allowed to produce bulk medications. Kazmira operates as a 503A facility.

A compounding facility that may produce medications in larger batches without patient-specific prescriptions. Typically supplies hospitals and clinics. Unlike 503A pharmacies, 503Bs are more akin to drug manufacturers and face different regulatory oversight.

A broad medical field focused on mental health, substance use, and emotional well-being.

A third-party lab report verifying ingredient identity, strength, and purity.

A pharmacy that prepares customized medications for individual patients based on a provider’s prescription.

A retail outlet that sells cannabis products. Kazmira is not affiliated with any dispensary and operates strictly within clinical channels.

The use of scientific research, clinical expertise, and patient input to inform treatment decisions.

International GMP guidelines for APIs used in pharmaceutical drugs.

A prescription written for a specific patient’s needs. Required for all compounded medications.

Ingredients and processes that meet FDA or ICH quality standards.

Medications made by licensed pharmacists according to a prescriber’s instructions.

The process of testing and verifying that medications meet specific standards for strength, purity, and identity.

A scientific nonprofit that sets standards for the quality, purity, and strength of medications. Kazmira follows USP compounding guidelines.

The process of adjusting medication dose to find the optimal balance between effectiveness and side effects.

The physical form in which a medication is administered (e.g., tincture, cream, softgel).

A specific mix of active and inactive ingredients compounded to meet the needs of an individual patient.

A natural additive used in Kazmira tinctures to improve taste and palatability.

A system that alerts patients when it’s time to reorder medication.

The way a drug is delivered to the body (e.g., oral, sublingual, topical).

A capsule-based oral delivery format, often used for consistent daily dosing.

A delivery method where medication is placed under the tongue for faster absorption.

A liquid medication taken orally, usually by dropper, designed for sublingual absorption.

The gradual adjustment of medication dose based on therapeutic response and tolerability.

The pure, biologically active component in a drug. Kazmira uses CBD Isolate Max® as the API in compounded formulations.

Standards that ensure pharmaceutical products are consistently produced and controlled. Kazmira follows ICH Q7 GMP for all API.

Refers to the pharmaceutical-grade refinement of CBD used in Kazmira formulations, free from contaminants and THC.

A biological response that contributes to pain and disease progression. CBD may help regulate inflammatory pathways.

A blood test that checks how well the liver is working. Used to monitor safety during CBD therapy.

Kazmira products contain 0.0% THC. No psychoactive effects.

In some states, veterinarians may prescribe compounded CBD for pets. Not currently available via Kazmira.

The set of physical or psychological symptoms that occur after stopping addictive substances. CBD may help reduce severity in some cases.